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ABSTRACT 
 A. Patterson, Steve E. Selig, Deidre Toia, Ralph H. Geerling, 
nt Bamroongsuk, David L. Hare. Comparing Methods For 
ing Exercise For Individuals With Chronic Heart Failure.  
ne 2005;8(4):9-19.  This study examined the accuracy of current 
ended guidelines for prescribing exercise intensity using the 
 of percentage of heart rate reserve (%HRR), percentage of 
k (%VO2peak) and percentage of VO2 reserve (%VO2R) in a 
opulation of chronic heart failure (CHF) patients.  The precision 
ription of exercise intensity for 45 patients with stable CHF (39:6 
±9 yrs (mean±SD)) was investigated. VO2peak testing is 
y common among patients with cardiac disease, but the 
ent of VO2rest is not common practice and the accepted 
 value of 3.5 mL/kg/min is assumed in the application of 
 (%VO2R3.5). In this study, VO2rest was recorded for 3 min prior 
art of a symptom-limited exercise test on a cycle ergometer. 
xercise intensities were calculated using the VO2 corresponding 
 80 %HRR, VO2peak and VO2R. The VO2 values were then 
d into prescribed speeds on a treadmill in km/hr at 1 %grade 
SM’s metabolic equation for walking. Target intensities and 
ed treadmill speeds were also calculated with the %VO2R 
using the mean VO2rest value of participants (3.9 mL/kg/min) 
3.9). This was then compared to the exercise intensities and 
ed treadmill speeds using patient’s measured VO2rest. Error in 
tion correlates the difference between %VO2R3.5 and %VO2R3.9 
d to %VO2R with measured VO2rest. Prescription of exercise 
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intensity through the %HRR method is imprecise for patients on medications that blunt the HR 
response to exercise. %VO2R method offers a significant improvement in exercise prescription 
compared to %VO2peak. However, a disparity of 10 % still exists in the %VO2R method using the 
standard 3.5 mL/kg/min for VO2rest in the %VO2R equation. The mean measured VO2rest in the 45 
CHF patients was 11 % higher (3.9±0.8 mL/kg/min) than the standard value provided by ACSM. 
Applying the mean measured VO2rest value of 3.9 mL/kg/min rather than the standard assumed 
value of 3.5 mL/kg/min proved to be closer to the prescribed intensity determined by the actual 
measured resting VO2. These results suggest that the %HRR method should not be used to prescribe 
exercise intensity for CHF patients. Instead, VO2 should be used to prescribe exercise intensity and 
be expressed as %VO2R with measured variables (VO2rest and VO2peak). 
 
Key Words: Metabolic equations, Chronic Heart Failure, %VO2R, Resting VO2
 
INTRODUCTION 
 
Physiological benefits gained from exercise training rely primarily on the intensity of the training 
stimulus. The prescribed intensity fraction can be alternatively applied using an absolute or relative 
approach. Absolute intensity is to prescribe a workload, such as 80 Watts on a cycle ergometer or a 
set caloric expenditure in a set time period (1). In this approach to intensity prescription, each person 
performing the set workload is under different physiological stress, relative to that person. 
Alternatively, exercise intensity is often prescribed by the relative physiological stress placed upon the 
body. The relative intensity is usually determined as a percentage of a maximum capacity, such as 
maximal heart rate, maximum oxygen capacity (VO2peak), or maximum exercise capacity (1). 
Subsequently, the target exercise intensity is prescribed by assigning a calculated value, which 
corresponds to a percentage of the particular maximum. 
 
This leads to two questions that should be addressed in order to establish optimal exercise training 
intensity for individuals with chronic heart failure (CHF): 
1. What is the optimal target range of exercise intensity for this population? 
2. How is the optimal target range of exercise intensity best determined? 
 
Individuals that are at high risk, such as those with cardiac, pulmonary, and other chronic diseases, 
who develop signs of exertional intolerance such as ischemia or hypoxemia at specific workloads, 
need an accurately computed and prescribed exercise intensity (2). Reference measures that have 
been used to computed and prescribe exercise in these patient populations include percentage of 
heart rate max (%HRmax), heart rate reserve (HRR), VO2peak, and more recently VO2 reserve 
(VO2R). The %HRmax method is often used with the general population by estimating HRmax as 220 
- age and establishing the target heart as a percentage of HRmax (2). %HRR refers to a percentage 
of the difference between resting HR and maximum HR (i.e., heart rate range).  
 
The formula used to calculate target HR by the %HRR method is:  
Target HR = (intensity fraction%)(HRmax – HRrest) + HRrest (3). 
 
This approach to calculating a target training heart rate gives a higher value compared to the heart 
rate computed as the percentage of HRmax, if both were calculated using the same percentage (e.g., 
70 %). Furthermore, the %HRR method more closely corresponds to a prescribed VO2 than does a 
set percentage of HRmax (4). For a healthy person, HR is a useful approach to prescribing intensity, 
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because it increases linearly with oxygen consumption and can be cross-referenced with other 
objective and subjective indices of exercise intensity (2). 
 
VO2peak describes the amount of oxygen a person uses per kilogram of body weight in one minute 
(mL/kg/min). The VO2peak value is a reasonable reference point from which to estimate exercise 
intensity as a percentage of VO2peak, in an analogous fashion to HRmax. In 1998, the American 
College of Sports Medicine (ACSM) proposed the use of a new reference for prescribing exercise, 
namely the oxygen consumption reserve indice (%VO2R) and in 2000 revised its exercise guidelines 
(2). Similar to %HRR, %VO2R represents a percentage of the difference between VO2rest and 
VO2peak.  
 
The formula used to calculate the target workload as a percentage of VO2R (%VO2R) is:  
Target work rate will correspond to the VO2 = (intensity fraction%)(VO2peak – VO2rest) + VO2rest (3). 
 
Exercise intensities have been recommended by the ACSM corresponding to 40-85 % of oxygen 
uptake reserve (%VO2R) or heart rate reserve (%HRR) for healthy adults and 40-50 % of VO2R or 
HRR for patients with heart disease (3). However, recommendations for patients with CHF have not 
been well established. Prior to ACSM including %VO2R as an alternative to exercise prescription, 
intensity for all people (healthy and patients) was prescribed as percentages of HRmax, HRR, and 
VO2peak. The reason for now questioning the use of these other methods is not due to a problem of 
over-prescribing exercise, but the reverse: exercise prescriptions were often of too low intensities to 
be effective in these patients. 
 
Studies show that using the %HRR method for exercise prescription will give intensities that are 
closer to the targeted intensity than by using the %HRmax method (2). That is assuming the resting 
HR, HRmax and rhythm are not affected by a person’s medical condition or medications. Most 
patients with CHF are on HR-modulating medications that modify the response to exercise. For 
instance, exercise prescription by HR is insensitive to patients taking prescribed medications that 
blunt the HR response to exercise (5) (e.g., Beta-blockers (3)). This could lead to errors and unsafe 
exercise prescription in this population (6).  
 
Medication therapy in CHF can influence HR (Table 1) leading to difficulties in calculating target HR 
intensities. Heart rate target range is often very narrow (7) due to high resting HR and low peak HR 
(e.g., atrial fibrillation), or low resting HR and low peak HR (e.g., beta-blockade) making it difficult to 
use the %HRR method. Thus, exercise prescription for patients with CHF should be based on VO2 
rather than HR. 
VO2R vs. %VO2peak Method 
Recent studies have shown that a disparity exists between %HRR and VO2peak with %HRR being 
more closely equivalent to %VO2R (8; 9). Thus, when intensities are set to a percentage of VO2R, the 
value is similar to the percent value for the HRR (8). However for the reasons already espoused 
above, %HRR is problematic in patients with heart failure.  
 
Findings from the Henry Ford Heart & Vascular Institute showed that when prescribing exercise to 
patients with heart disease based on VO2, relative intensity should be given as %VO2R (10). Target 
intensity using this method is calculated by the VO2R formula: Target VO2 = (intensity 
fraction)(VO2peak – VO2rest) + VO2rest.  
Measured Resting VO2 vs. Predicted Resting VO2
The next step in accurate and valid exercise prescriptions for these patients is to accurately measure 
resting VO2 as well as VO2peak. Average resting VO2 is widely assumed to be 3.5 mL/min/kg and is 
recommended by ACSM to be used in the %VO2R formula (3). Although research has shown that 
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%VO2R is closer to %HRR than %VO2peak in a healthy population, it has been reported that there is 
a 6% discrepancy between %HRR and %VO2R in heart failure (10). To examine this further, resting 
VO2 was measured in patients in the present study.  
 
Table 1. Effects of Medications on HR, BP, the ECG, and Exercise Capacity. 
Medications HR BP ECG Exercise Capacity 
β-Blockers (including 
carvedilol, labetalol) 
↓ (R and E) ↓ (R and E) ↓ HR (R) 
↓ ischemia (E)  
↑ in patients with 
angina 
↓ or ↔ in patients 
without angina 
Nitrates ↑ (R) 
↑ or ↔ (E) 
↓ (R)  
↓ or ↔ (E) 
↑ HR (R) 
↑ or ↔ HR (E) 
↓ ischemia (E) 
↑ in patients with 
angina 
↔ in patients without 
angina 
↑ or ↔ in patients 
with CHF 
Digitalis ↓ in patients with AF 
and possibly CHF  
Not significantly 
altered in patients 
with SR 
↔ (R and E) May produce 
nonspecific ST-T 
wave changes (R) 
May produce ST 
segment depression 
(E)  
Improved only in 
patients with AF or in 
patients with CHF 
Diuretics ↔ (R and E) ↔ or ↓  (R 
and E) 
↔ or PVCs (R)  
May cause PVCs 
and “false positive” 
test results if 
hypokalemia occurs 
May cause PVCs if 
hypomagnesemia 
occurs (E) 
↔, except possibly in 
patients with CHF 
Vasodilators, 
nonadrenergic 
↑ or ↔ (R and E) ↓  (R and E) ↑ or ↔ HR (R and 
E) 
↔, except  ↑ or ↔ in 
patients with CHF 
ACE Inhibitors ↔ (R and E) ↓  (R and E) ↔ (R and E) ↔, except  ↑ or ↔ in 
patients with CHF 
Adapted from ACSM 2000 
↑ = increase; ↔ = no effect; ↓ = decrease; R = rest; E = exercise; HR = heart rate; PVCs = premature ventricular 
contractions; AF = atrial fibrillation; SR = sinus rhythm 
 
METHODS 
Participants  
The cohort consisted of 45 patients with stable CHF (39:6 male:female) aged 65±9 years (mean±SD), 
left ventricular ejection fraction (LVEF%) 27±7%, and the number of patients with New York Heart 
Association functional classification II and III was 31 (69 %) and 14 (31 %), respectively. Twenty-nine 
patients had ischaemic cardiomyopathy, one had valvular disease, and the other 15 had dilated 
cardiomyopathy. Most were on an angiotensin converting enzyme inhibitor or angiotensin receptor 
blocker, and a diuretic. These and other medications that patients were taking at entry into the study 
are summarized in Table 2. 
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Exercise Testing Table 2. Descriptive characteristics of the 45 CHF 
Patients who underwent VO2peak testing.  
CHF patients (n=45) Characteristics 
Age, yrs 65 ± 9 
Male / Female 39 / 6 
Height (cm) 170 ± 8 
Body mass (kg) 81.5 ± 15 
LVEF% 27 ± 7 
NYHA 2.3 ± 0.5 
Body mass index (kg/m) 27.9 ± 5.6 
Peak VO2 (mL/kg/min) 15.7 ± 4.3 
Peak heart rate (beats/min) 126 ± 25 
Resting heart rate (beats/min) 73 ± 15 
RPEpeak  16.7 ± 1.5 
RERpeak  1.16 ± 0.15 
CHF diagnosis N (%)  
Ischemic heart disease 29 (64%) 
Dilated cardiomyopathy 15 (33%) 
Valvular 1 (2%) 
Rhythm N (%)  
Sinus 35 (78%) 
Atrial Fibrillation 7 (15%) 
Paced 3 (7%) 
Medications N (%)  
ACE inhibitor or 
angiotensin receptor 
blocker 
35 (78%) 
Diuretic 38 (84%) 
Beta-blocker 21 (47%) 
Digoxin 18 (40%) 
Aspirin 27 (60%) 
Warfarin 19 (42%) 
Amiodarone 7 (16%) 
Nitrates 8 (18%) 
Calcium channel 
antagonist 
4 (9%) 
RPEpeak, peak self-rating of perceived exertion (Borg 6-
20 point scale); RERpeak, (VCO2/VO2 ratio); LVEF, left 
ventricular ejection fraction; NYHA, New York Heart 
Association. 
VO2peak tests were conducted in a hospital 
exercise laboratory. After written, informed 
consent was obtained; all participants 
underwent a familiarization maximal bicycle 
exercise test one week prior to baseline 
testing to decrease effects of anxiety on 
VO2rest. Patients were given several minutes 
to adapt to the mouth piece and two-way 
non-rebreathing valve, then resting VO2 
values were recorded for 3 min prior to the 
start of exercise in an upright position. 
 
Peak total body oxygen consumption 
(VO2peak) was determined during a 
symptom-limited graded exercise test (17) on 
an electronically-braked cycle ergometer 
(Ergomed, Siemens, Erlangen, Germany), 
commencing at 10 Watts and increasing by 
10 Watts/min. Measurements were made 
each minute for VO2 and VCO2 (OM-11 
Medical Oxygen Gas Analyser, and LB2 
Medical Carbon Dioxide Gas Analyser; 
Beckman, Fullerton, CA, USA), minute 
ventilation (VE (BTPS), 47304A respiratory 
flow transducer with Fleisch pneumotach, 
Hewlett Packard, USA), heart rate (EK43 
Multiscriptor 12 lead ECG, Hellige, Belgium), 
arterial oxygen saturation (Biox 3700 Pulse 
Oximeter, Oxi-Radiometer, Boulder, 
Colorado, USA) and self-ratings of perceived 
exertion. Respiratory exchange ratio (RER) 
was measured each minute and RERpeak 
and HRpeak were used as indices of 
metabolic stress at the end of the VO2peak 
test. All instrumentation used in the 
measurement of VO2peak was calibrated 
using standard methods before and 
immediately after each test. Patients 
continued cycling until they were no longer 
able to maintain at least 60 rev/min, or 
cardiovascular signs or symptoms 
intervened.  
Statistical Analyses 
Exercise intensities of 50 and 80 % were 
used to match against the study by Brawner 
et al (10). Target rates were calculated by 
using %VO2R in mL/kg/min and converting 
the values into prescribed speed on a 
treadmill in km/hr on a 1% grade. A grade of 
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1% was selected because it caused less musculo-skeletal and joint jarring than 0%, as many 
individuals with CHF also have arthritic hips and knees. Prescribed speeds for each patient were 
calculated using the methods of %HRR, %VO2peak, %VO2R3.5 and %VO2R using the mean VO2rest 
value of the studies participants (3.9 mL/kg/min; %VO2R3.9) and was then compared to each patient’s 
measured resting VO2. ANOVA’s with repeated measures were applied with post-hoc analyses 
conducted using the LSD method to locate the means that were significantly different. All of these 
statistical analyses were performed using SPSS (version 13; Chicago, IL). The level of significance 
was set at P<0.05 for all variables. All data are 
reported as mean±SD. 
 
RESULTS 
 
Subject characteristics were described in 
Methods and Table 2.  All 45 patients were able 
to complete the testing, although two had 
discomfort with the mouthpiece and were not 
included in the overall analysis. 
 
To reveal the theoretical basis of the heart rate 
estimation method when using individuals with 
disease, Figure 1-3 present representative heart 
rat responses.  Figure 1 presents heart rate 
response curves for a heart rate medicated 
individual with CHF and a non-diseased 
individual.  Figures 2 and 3 compare the heart 
rate extrapolation for exercise prescription for a normal (Figure 2) and diseased and medicated 
(Figure 3) individual. 
 
The disparities between the four methods of %HRR, %VO2peak, %VO2R3.5, and %VO2R3.9, compared 
to %VO2R using a measured VO2rest are shown collectively in Figure 4. Exercise prescription based 
on %VO2R with resting VO2 measured and %VO2R3.9 were not significantly different from one 
another. In contrast, prescription using %VO2R3.5, %VO2peak and %HRR were all significantly 
different from the actual resting VO2 measured value. 
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Figure 2. Representation of a normal linear heart 
rate response to exercise in an adult on no 
medication and showing a small margin of error 
in prescribed exercise intensity when HR is used.
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Figure 3. Representation of the HR response to exercise 
in a patient with CHF caused by prescribed medication 
and how it magnifies the error in exercise prescription 
when HR is used. 
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Table 3 presents results of the statistical analyses for pair-wise comparisons of the data of Figure 4. 
 
DISCUSSION 
 
Heart rate is widely used for exercise 
prescription in the general community, 
and in most situations involving 
exercise, serves as a parameter of 
metabolic rate. In laboratory-based 
exercise testing, metabolic rate is often in
non-laboratory situations, VO2 testing is im
linear relationship between heart rate and
used. The exercising heart rate or percen
intensity. The use of %HRR method of pr
between maximum heart rate and resting
assumption that %HRR will yield the sam
VO2peak. However, %HRR is the differen
is thought to correspond very closely to th
maximum oxygen consumption (VO2 Res
 
Precise prescription of exercise intensity 
benefit from training regimes. Although nu
have been completed, the range of intens
(11) to 75% (12) VO2peak, 50% (13) to 85
60% of HR Reserve (16), and a Rate of P
program should be patient-specific, tailore
of 50%, 70%, and 80% of maximal exertio
beneficial and cause positive physiologica
(THR) derived by the heart rate reserve (%
percentage of functional capacity are ofte
a recent study, 52 patients with left ventri
prescribing exercise intensity (19). Exerci
responses in this population such as vent
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Figure 4. Errors for four methods of prescribing exercise in 
patients with CHF. For each, the error represents the % 
difference between the exercise intensity predicted by the 
method (%HRR, %VO2peak, %VO2R3.5, %VO2R3.9), compared to 
the actual measurement during the symptom-limited graded 
exercise test. Table 3. Comparison of disparities 
between prescribed exercise intensities 
based on %VO2R with measured VO2rest, 
using the methods of %HRR, %VO2peak,
%VO2R3.5 , and %VO2R3.9.  
CHF Patients (N = 43) 
Method (at 50 and 80%) P value 
%HRR  0.997 
%VO2peak 0.969 
%VO2R (3.5 mL/kg/min) 0.489 
%VO2R (3.9 mL/kg/min) 0.034* 
* P<0.05 dexed by oxygen consumption (VO2). However, in most 
practical. To overcome this, the assumption that there is a 
 oxygen consumption during exercise has traditionally been 
tage of heart rate has been used to estimate exercise 
escribing target heart rates, which uses the difference 
 heart rate, has been commonly applied, based on the 
e exercise intensity as the equivalent percentage of 
ce between resting heart rate and maximum heart rate and 
e difference between resting oxygen consumption and 
erve) (3), not gross oxygen consumption (VO2peak).  
should be established for CHF in order to gain maximum 
merous trials concerning the effects of exercise in CHF 
ities that have been prescribed to patients varies from 40% 
% (14) of maximum HR, 70% to 80% (15) of peak capacity, 
erceived Exertion of 12-14 (17). The exercise-training 
d to any limitations or desired activity level. Intensity levels 
n during aerobic interval training have shown to be 
l responses in individuals with CHF (18). Target heart rate 
HRR) method, rating of perceived exertion (RPE), and/or a 
n used for cardiac rehabilitation programs (19). However, in 
cular dysfunction were tested to assess methods of 
sing at high intensities can cause negative physiological 
ricular arrhythmias, thrombus formation, decreased left 
 (20) thus, the target intensity used in the study was ±10% 
hreshold (VT) (VT-HR ± 10%). Patients underwent an 
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exercise test reaching VT to determine exercise prescription as VT-HR ± 10% and compare it to the 
%HRR method set at intensities of 60 %, 70 %, and 80 % and rate of perceived exertion (RPE) level 
11 and 13. Results showed that there was no significant correlation between VT-HR ± 10% and RPE 
level 11-13. Only 50 % of the patients fell into the correct intensity level using this method and less 
than 40 % when using the %HRR method were below the VT. These findings of common errors in 
exercise prescription are similar to the results shown in this study, however, the use of VT-HR ± 10% 
does not take into account the everyday disparities in HR that are found in this population due to 
medications that blunt the HR response to exercise. In individuals with CHF, prescribed medications, 
such as beta-blockers, alter resting and/or maximum heart rate. A large disparity occurs between 
increases in heart rate to work rate ratio when compared to the healthy population resulting in an 
inappropriate prescription of intensity even when matching against VT. Other researchers have also 
suggested the use of VT as an alternative (21,22). In a study by Oka et al., only 69% of the heart 
failure patients had a measurable VT, showing how difficult and unreliable detecting VT in this 
population is (22). Since using HR for exercise prescription in these individuals is unreliable, a VO2 
method should be considered. Results show a significant error when prescribing exercise intensity 
with %VO2peak method (Figure 4 and Table 3). This suggests that individuals with CHF should have 
prescribed exercise intensities determined by the method of %VO2R rather than by %HRR or 
%VO2peak.  
 
To provide the required variables of the %VO2R equation, resting VO2 must be measured or 
otherwise assumed. When exercise intensity is determined from %VO2R method with a measured 
resting VO2 there is little error in the prescription. However, in most cases resting VO2 is not 
measured and a standard value of 3.5 mL/kg/min provided by the ACSM is inserted. This study 
showed that patients with CHF have an increased resting VO2 compared to healthy volunteers. When 
the %VO2R method is used to prescribe exercise intensity for individuals with CHF a disparity exists 
when the standard resting VO2 value of 3.5 mL/kg/min is used (+10%). Although this disparity is 
substantially less than observed with the %VO2peak method, it is still different compared to the 
prescribed exercise intensity using the patients measured resting VO2. Exercise prescription based 
on %VO2R using 3.9 mL/kg/min as resting VO2 is more closely related to %VO2R with a measured 
resting VO2. This is a significant finding because, endurance and strength training can be used safely 
in rehabilitation programs (23) and is a recommended intervention for people with cardiovascular 
disease (24), and recently including individuals with CHF (25).  
 
Although, %VO2R has been shown to be closely related to %HRR in the healthy population, a 
discrepancy between the two still occur (10). Brawner et al. (10) reported an 8 % disparity in CHF 
patients that are on beta-blockers, while there was only a 0.9% difference in patients with myocardial 
infarctions on beta-blockers (10). Their findings on individuals with CHF are relatively similar to the 
10% disparity observed in this study. Patients with myocardial infarctions in the Brawner et al. (10) 
study were without a history of coronary revascularization and no left ventricular dysfunction, whereas 
the individuals with CHF had a resting left ventricular ejection fraction ≤ 35%. Thus, beta-blockade 
may have been more heavily prescribed in the CHF group, although this data was not provided. 
Furthermore, the average age in their HF group was 53 years with an average peak heart rate of 
135±23 beats/min (average resting heart rate was not provided). The age is significant because it is 
related to a higher average in HRmax than is commonly seen in this population. As therapy has 
improved in the past decade the average age has increased. The average HRmax measured by 
Brawner et al. (10) is 9 beats/min higher than the group used in this study which had an average age 
of 65±9 years. Thus, the older the age group the greater the disparity. This may explain the greater 
disparity reported in this study (10 %) compared to Brawner et al. (10) (8 %). Other studies have 
included a measured VO2rest (8), but in each case this data was not reported. Brawner et al. (10) 
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stated that a limitation to their study was the absence of a measured VO2 at rest, they recalculated 
the regressions using 4.2 mL/kg/min (a value reported by (26), as resting VO2 while standing) and 
reported less disparity than with 3.5 mL/kg/min. This elevated oxygen consumption is not surprising 
considering the characteristics observed in this patient population. Higher VO2rest is probably due to 
increased ventilatory demand and/or reduced ventilatory metabolic efficiency at rest. Individuals with 
CHF have an exaggerated ventilatory requirement at rest and during exercise (27; 28). 
Deoxygenation of the accessory respiratory muscles (29), increased work of breathing (30), and 
decreased strength of the respiratory muscles (31) have been reported in this patient population. 
Together, these could be expected to exert influences on VO2rest. 
 
There are several significant implications from these data. First, exercise prescription through the 
%HRR method is insensitive to patients taking prescribed medications that blunt the HR response to 
exercise. In this group, prescribed medications alter resting and/or max heart rate. A large disparity 
occurs between increases in heart rate to work rate ratio when compared to the healthy population 
resulting in an inappropriate prescription of intensity. Second, using HR for exercise prescription in 
these individuals is unreliable, thus one of the VO2 methods should be considered. Third, %VO2R is 
significantly more accurate than %VO2peak. When prescribing exercise intensity to patients with 
CHF, the %VO2R method should be used. The results support Brawner et al.’s recent 
recommendations for the use of %VO2R in patients with heart disease and now more specifically in 
the population of CHF. The final implication is that this method, although more accurate than 
%VO2peak, over predicts prescription of exercise by as much as 10%. The introduction of 3.9 
mL/kg/min as the standard VO2rest value for individuals with CHF, at least for patients with the 
clinical backgrounds of the current cohort of 45, reduces much of the remaining disparity. Individuals 
with CHF exhibited a higher resting VO2 than the standard given value provided by ACSM. The 
ACSM recommends an assumed value of 3.5 mL/kg/min to represent VO2rest. This is used whether 
the ensuing exercise is cycling or ambulatory exercise such as stepping or treadmill exercise. The 
approach used in this study was to actually measure VO2rest in each individual while sitting upright 
on the cycle erogometer, as one of the input variables in the calculation of VO2R. This has two 
advantages over an assumed 3.5 mL/kg/min:  (i) this accounts for upright, seated posture used in 
cycling exercise which has been the most common mode of exercise used in published studies, and 
(ii) the actual VO2rest was measured, rather than an assumed value. 
 
Many problems still remain with respect to the safe, yet effective, exercise prescription for individuals 
with CHF. It was recently demonstrated in a study of our own (32) that moderate exercise intensity 
(RPE 12-14 (which is equivalent to 40 to 60 %VO2R)) is beneficial for these patients. Exercise 
training at a moderate intensity for three months increases exercise capacity, skeletal muscle 
strength and endurance, and improves peripheral blood flow. This study showed that exercise 
intensities should be calculated by the %VO2R method and established the importance of exercise 
testing in the CHF population. It appears prudent that exercise testing should be recommended for 
individuals with CHF and resting oxygen consumption obtained when possible for an accurate 
prescription of exercise intensity. 
 
CONCLUSIONS 
 
This study demonstrates that individuals with CHF have a blunted heart rate response to exercise 
compared to the healthy population. The altered HR response is most likely a result of prescribed 
medication and has a significant effect on prescribed exercise intensities determined by %HRR 
method. Thus, %HRR should not be used to calculate intensity for this high-risk patient population. 
The use of oxygen consumption is more reliable in these patients. Using %VO2R method for 
prescribing exercise intensity is more accurate than %VO2peak. When prescribing exercise intensity 
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to patients with CHF the %VO2R method should be used with measured variables (VO2rest and 
VO2peak). In situations where VO2rest cannot be established, 3.9 mL/kg/min should be used in place 
of 3.5 mL/kg/min. 
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